NAD(P)H oxidase and pro-inflammatory response during maximal exercise: Role of C242T polymorphism of the p22phox subunit

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 1, 2010, Pages 203-211

  Izzicupo, P ^a   Di Valerio, V ^a   D'Amico, M A ^a   Di Mauro, M ^a   Pennelli, A ^a   Falone, S ^b   Alberti, G ^c   Amicarelli, F ^b   Miscia, S ^a   Gallina, S ^a   Di Baldassarre, Angela ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

MPO; Oxidative stress; Respiratory burst; VO2max

Indexed keywords

HYDROCORTISONE; MYELOPEROXIDASE; PROTEIN P22PHOX; PROTEIN SUBUNIT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ADULT; AEROBIC EXERCISE; ALLELE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHLETE; CARDIOPULMONARY EXERCISE TEST; DNA POLYMORPHISM; ENDURANCE; GENE MUTATION; GENETIC VARIABILITY; HEART RATE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; NORMAL HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RUNNING;

EID: 77951751551     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300118     Document Type: Article

References (35)

1. Brown WJ, Burton NW, Rowan PJ. Updating the evidence on physical activity and health in women. Am J Prev Med 2007; 33:404-411
2. Keaney JF Jr, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23:434-439 (Pubitemid 36337219)
3. Inoue T, Node K. Vascular failure: A new clinical entity for vascular disease. J Hypertens 2006; 24:2121-2130 (Pubitemid 44611016)
4. Takimoto E, Kass DA. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 2007; 49:241-248 (Pubitemid 46142995)
5. Gleeson M. Immune function in sport and exercise. J Appl Physiol 2007; 103:693-699
6. Nielsen S, Pedersen BK. Skeletal muscle as an immunogenic organ. Curr Opin Pharmacol 2008; 8:346-351
7. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schonbein GW, Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 2000; 36:878-884
8. Falone S, Mirabilio A, Passerini A, Izzicupo P, Cacchio M, Gallina S, Di Baldassarre A, Amicarelli F. Aerobic performance and antioxidant protection in runners. Int J Sports Med. 2009; 30:782-788
9. Adams V, Linke A, Krankel N, et al. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation 2005; 111:555-62. (Pubitemid 40216482)
10. Di Mauro M, Izzicupo P, Santarelli F Amicarelli F, Calafiore AM, Di Baldassarre A, Gallina S. ACE and AGTR1 polymorphisms and left ventricular hypertrophy in endurance athletes, (in press).
11. Doerries C, Grote K, Hilfiker-Kleiner D, et al. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res 2007; 100:894-903. (Pubitemid 46555695)
12. Hernandez D, de la Rosa A, Barragan A, et al. The ACE/DD genotype is associated with the extent of exercise-induced left ventricular growth in endurance athletes. J Am Coll Cardiol 2003; 42:527-532 (Pubitemid 36951722)
13. Akhmetov, II, Linde EV, Shikhova Iu V, Popov DV, Missina SS, Vinogradoba OL, Rogozkin VA. The influence of calcineurin gene polymorphism on morphofunctional characteristics of cardiovascular system of athletes. Ross Fiziol Zh Im IM Sechenova 2008; 94:915-922
14. Henderson J, Withford-Cave JM, Duffy DL, Cole SJ, Sawyer NA, Gulbin JP, Hahn A, Trent RJ, Yu B. The EPAS1 gene influences the aerobic-anaerobic contribution in elite endurance athletes. Hum Genet 2005; 118:416-423 (Pubitemid 43091212)
15. Park JY, Ferrell RE, Park JJ, Hagberg JM, Phares DA, Jones JM, Brown MD. NADPH oxidase p22phox gene variants are associated with systemic oxidative stress biomarker responses to exercise training. J Appl Physiol 2005; 99:1905-1911
16. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG.. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003; 111:1201-1209 (Pubitemid 36519937)
17. Di Francescomarino S, Sciartilli A, Di Valerio V, Di Baldassarre A, Gallina S. The effect of physical exercise on endothelial function. Sports Med 2009; 39:797-812.
18. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000; 87:26-32. (Pubitemid 30456931)
19. Battistoni A, Ajello M, Ammendola S, Superti F, Rotilio G, Valenti P. Involvement of reactive oxygen species in bacterial killing within epithelial cells. Int J Immunopathol Pharmacol 2004; 17:71-76 (Pubitemid 39572190)
20. Cooper DM, Radom-Aizik S, Schwindt C, Zaldivar F, Jr. Dangerous exercise: lessons learned from dysregulated inflammatory responses to physical activity. J Appl Physiol 2007; 103:700-709 (Pubitemid 47208436)
21. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4:181-189
22. Soccio M, Toniato E, Evangelista V, Carluccio M, De Caterina R. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur J Clin Invest 2005; 35:305-314 (Pubitemid 40675604)
23. Zafari A M, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison D G, Taylor WR, Griendling KK. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998; 32:488-495 (Pubitemid 28429138)
24. Krex D, Ziegler A, Konig IR, Schackert HK, Schackert G. Polymorphisms of the NADPH oxidase P22PHOX gene in a Caucasian population with intracranial aneurysms. Cerebrovasc Dis 2003; 16:363-368 (Pubitemid 37140425)
25. Wyche KE, Wang SS, Griendling KK, Dikalov SI, Austin H, Rao S, Fink B, Harrison DG, Zafari AM. C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 2004; 43:1246-1251 (Pubitemid 38696914)
26. Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 2005; 65:16-27. (Pubitemid 40038475)
27. Munzel T, Sinning C, Post F, Warnholtz A, Schulz E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med 2008; 40:180-196 (Pubitemid 351482543)
28. Kocer G, Senturk UK, Kuru O, Gunduz F. Potential sources of oxidative stress that induce postexercise proteinuria in rats. J Appl Physiol 2008; 104:1063-1068
29. Schneider MP, Hilgers KF, Huang Y, Delles C, John S, Oehmer S, Schmieder RE. The C242T p22phox polymorphism and endothelium-dependent vasodilation in subjects with hypercholesterolaemia. Clin Sci (Lond) 2003; 105:97-103.
30. Stanger O, Renner W, Khoschsorur G, Rigler B, Wascher TC. NADH/NADPH oxidase p22 phox C242T polymorphism and lipid peroxidation in coronary artery disease. Clin Physiol 2001; 21:718-22.
31. McIntosh LJ, Sapolsky RM. Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp Neurol 1996; 141:201-206
32. Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. Faseb J 2006; 20:1546-8.
33. Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular mechanisms. Physiol Rev 2008; 88:287-332.
34. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998; 97:135-137
35. Kullo IJ, Khaleghi M, Hensrud DD. Markers of inflammation are inversely associated with VO2 max in asymptomatic men. J Appl Physiol 2007; 102:1374-1379